KB Home
KBH
MicroStrategy
MSTR
Meritage Homes
MTH
Toll Brothers
TOL
D.R. Horton
DHI
US Stock MarketDetailed Quotes
CLPT ClearPoint Neuro
- 14.695
- -0.705-4.58%
Close Jan 14 16:00 ET
405.36MMarket Cap-21.30P/E (TTM)
15.930High14.280Low291.30KVolume15.440Open15.400Pre Close4.35MTurnover1.15%Turnover RatioLossP/E (Static)27.58MShares17.47052wk High13.98P/B373.54MFloat Cap5.10552wk Low--Dividend TTM25.42MShs Float31.290Historical High--Div YieldTTM10.71%Amplitude2.860Historical Low14.944Avg Price1Lot Size
ClearPoint Neuro News
ClearPoint Neuro | 4: Statement of changes in beneficial ownership of securities-Officer BURNETT JOSEPH MICHAEL
ClearPoint Neuro | 4: Statement of changes in beneficial ownership of securities-Officer STIGALL L. JEREMY
ClearPoint Neuro | 4: Statement of changes in beneficial ownership of securities-Officer SABRA MAZIN
ClearPoint Neuro | 4: Statement of changes in beneficial ownership of securities-Officer D'Alessandro Danilo
ClearPoint Neuro | 4: Statement of changes in beneficial ownership of securities-Director LIAU LINDA M.
ClearPoint Neuro | 4: Statement of changes in beneficial ownership of securities-Director Richards Timothy T.
ClearPoint Neuro | 4: Statement of changes in beneficial ownership of securities-Director FLETCHER R JOHN
ClearPoint Neuro | 4: Statement of changes in beneficial ownership of securities-Director Girin Pascal E R
ClearPoint Neuro | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(4.50%)
ClearPoint Neuro | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)
ClearPoint Neuro | 8-K: Current report
ClearPoint Neuro | 424B5: Prospectus
ClearPoint Neuro | 10-Q: Q3 2024 Earnings Report
ClearPoint Neuro | 8-K: ClearPoint Neuro Reports Third Quarter 2024 Results
ClearPoint Neuro | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(4.50%)
ClearPoint Neuro | 4: Statement of changes in beneficial ownership of securities-Officer SABRA MAZIN
ClearPoint Neuro | 4: Statement of changes in beneficial ownership of securities-Director Girin Pascal E R
ClearPoint Neuro | 4: Statement of changes in beneficial ownership of securities-Director Richards Timothy T.
ClearPoint Neuro | 4: Statement of changes in beneficial ownership of securities-Director LIAU LINDA M.
ClearPoint Neuro | 4: Statement of changes in beneficial ownership of securities-Director FLETCHER R JOHN
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
